Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11230545
Heterocyclic compound
granted -
US 11229700
Trispecific molecule combining specific tumor targeting and local immune checkpoint inhibition
granted -
US 11230537
Polymorphs of n-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[2-oxopyridin-1-yl)methyl]phenyl} methyl)pyrazole-4-carboxamide as iallikrein inhibitors
granted -
US 11230536
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
granted -
US 11229702
High concentration formulations of adalimumab
granted -
US 11229663
Serum amyloid P component (APCS) iRNA compositions and methods of use thereof
granted -
US 11229687
TPP-1 formulations and methods for treating CLN2 disease
granted -
US 11229636
Substituted tetrahydroquinolinone compounds as ROR gamma modulators
granted -
US 11229647
Methods for treating cholestasis
granted -
US 11229679
Compositions for treating heart disease by inhibiting the action of mAKAPβ
granted -
US 11229684
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11229609
Compositions and methods for organ specific delivery of nucleic acids
granted -
US 11229600
Compositions and methods for selective GI tract delivery
granted -
US 11229599
Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
granted -
US 11229630
Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs
granted -
US 11230712
Compounds and methods for reducing SNCA expression
granted -
US 11230596
Methods for treatment of cancer comprising TIGIT-binding agents
granted -
US 11224626
Methods of identifying bacteriophages that can infect and kill host-adapted infectious pathogenic bacteria
granted -
US 11225664
Modulation of angiopoietin-like 3 expression
granted -
US 11225648
Modified DNase and uses thereof
granted -
US 11225525
Antibodies for botulinum neurotoxins
granted -
US 11225506
Cell penetrating peptides and methods of making and using thereof
granted -
US 11225662
Peptide oligonucleotide conjugates
granted -
US 11225650
Methods of using FIX polypeptides
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.